鍵凱科技：注射用聚乙二醇伊立替康新適應癥II期臨床試驗獲批

array(1) { [375833]=> array(2) { [2]=> array(3) { [0]=> string(12) "臨床試驗" [1]=> string(12) "鍵凱科技" [2]=> string(12) "聚乙二醇" } [4]=> array(1) { [0]=> string(19) "同花順7x24快訊" } } }